Increasing Prevalence Of Chronic Lung Disorder To Boost The Growth Of Burkholderia Infections Market

Burkholderia Infections Market
Burkholderia Infections Market

Burkholderia Infections Market By Drug (Trimethoprim, Sulfamethoxazole, Trimethoprim & Sulfamethoxazole, Mucolytics, Meropenem, Minocycline, Cefepime, Tigecycline, Bronchodilators, Fluoroquinolones & Others), By Route of Administration (Oral, Injectables, Topical & Others), By End-user (Hospital & clinics, Ambulatory Care Centres, Elderly Care Centres & Others), By Distribution Chanel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy & Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

The global Burkholderia Infections Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Burkholderia is an aerobic gram-negative bacteria that can be observed in soil and water. Burkholderia is an organism of less virulence and are frequently resistive to collective antigens. Symptoms of burkholderia differ from person to person.

Competitive Landscape:

Key players involved the global Burkholderia infection for market are iQur Ltd., NanoBio Corporation, Novabiotics Ltd, Aridis Pharmaceuticals LLC, among others.

Market Key Drivers:

Increasing prevalence of chronic lung disorder is expected to augment the growth of global Burkholderia Infections Market. For instance, as per WHO, around 3.23 million deaths occurred due to COPD in 2019. COPD is considered to be the third dominant cause for fatality in people.

The rising asthma cases are projected to propel the growth of global Burkholderia infection market. For instance, as per WHO, around 262 million people got affected by asthma globally in 2019.

Covid-19 Impact Analysis:

The Covid-19 had a positive impact on the growth of the market as the pandemic was directly linked to the problems such as short breath, breathlessness and other respiratory problems. It directly affected to the lungs, liver and other vital organs. The rise in surge led to an increase in the number of growing COPD disorders.

Key Takeaways:

The global Burkholderia Infections Market is anticipated to exhibit a CAGR of XX % during the forecast period owing to increasing prevalence of cystic fibrosis. For instance, as per CFF around 70,000 people suffer from cystic fibrosis globally.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in the global Burkholderia infection for market due to rising approvals and launches, the rising prevalence of asthma, cystic fibrosis, COPD and the rising healthcare infrastructure. For instance, as per AAFA.org, around 9.8% women and 6.1% men suffer from asthma in India.

Comments

Popular posts from this blog

Vehicle-To-Vehicle (V2V) Communication; Used To Wirelessly Interchange Data Regarding Their Speed, Place, And Heading

Global Polyphenol Market Is Expanding Owing To Growing Development Of Polyphenol-Rich Products For Health Improvement

Global Ferrous Sulfate Market Is Anticipated To Witness High Growth Due To Growing Demand In The Water Treatment Segment And Increasing Applications In Cement And Agriculture